Following Today's Kosan (KOSN) Buyout, Investors Look for Next Biotech Deal
More News related to AFFY
- Affymax Announces Completion of Final Scheduled Data Monitoring Committee Review of Phase 3 Hematide Program
- Affymax and Takeda Announce Hematide(TM) Publication in the New England Journal of Medicine
- Affymax (AFFY) Posts Q3 Loss of $0.97, Narrower than Expected
- Affymax(R) Reports Third Quarter 2009 Financial Results
- Affymax Names Hollings C. Renton Chairman of the Board of Directors
More News related to ARQL
- ArQule, Inc. to Present at Lazard Capital Markets Sixth Annual Healthcare Conference on November 17, 2009
- ArQule (ARQL) Posts Q3 Loss of $0.18, Beats Estimates; Reaffirms Guidance
- ArQule Announces Third Quarter Fiscal 2009 Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
- ArQule, Inc. to Report Third Quarter 2009 Financial Results on Thursday, November 5, 2009
More News related to BMRN
- United States Patent Office Issues Patent Covering the Approved Administration of Kuvan With Food
- BioMarin to Present at the Credit Suisse Healthcare Conference
- Morgan Joseph Reiterates a 'Buy' on BioMarin Pharmaceutical (BMRN)
- Credit Suisse Upgrades BioMarin Pharmaceutical (BMRN) to Overweight
- BioMarin Pharmaceutical (BMRN) Tops Q3 EPS by 12c; Guides
More News related to Insiders' Blog
- Trading Radar for 11/11: Macy's (M), Progressive (PGR), Advanced Auto Parts (AAP), Computer Sciences (CSC) Report
- Unusual 11 Mid-Day Movers 11/10: UPG, CSII, SGK, MEDQ Higher; RHIE, OPXT, PRKR, MBI Lower
- Notable ETF Movers: PGM, XLV, SMH Up; UNG, KRE, FXI, AGQ, XME Down
- Notable Analyst Rating Changes 11/10: ADBE, ANN, FRPT, RAX Upgraded; ALU, CPST, PIKE, TRW Downgraded
- Morning Movers 11/10: UPG, CYD, PCLN, FLL, BZH Higher; RHIE, OPXT, PRKR, PIKE, MBI, SDTH Lower
Following today's buyout of small biotech Kosan Biosciences, Inc. (NASDAQ: KOSN) by Bristol-Myers Squibb (NYSE: BMY) at a 200%+ premium, investors are on the lookout for the next biotech deal.
Today's deal follows other recent biotech takeovers including Millennium Pharmaceuticals (NASDAQ: MLNM), Sirtris Pharmaceuticals (Nasdaq: SIRT), Encysive Pharmaceuticals Inc. (Nasdaq: ENCY), and Restore Medical, Inc. (NASDAQ: REST).
Here are some biotech companies that could be next to be acquired: Onyx Pharmaceuticals (NASDAQ: ONXX), OSI Pharmaceuticals (NASDAQ: OSIP), ImClone (NASDAQ: IMCL), ISIS Pharmaceuticals (NASDAQ: ISIS), BioMarin Pharmaceutical (NASDAQ: BMRN), ArQule (NASDAQ: ARQL), Regeneron (NASDAQ: REGN), Affymax (NASDAQ: AFFY), Medivation (NASDAQ: MDVN).
Related Categories
Insiders' BlogRumors
Stocks Mentioned
-0.50
+0.36Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
